"
Preoperative Prediction of Whether Intraoperative Fluorescence of Protoporphyrin IX Can Be Achieved by 5-Aminolevulinic Acid Administration"
written by Satoshi Utsuki, Hidehiro Oka, Chihiro Kijima, Madoka Inukai, Kiyotaka Fujii, Masahiro Ishizuka, Kiwamu Takahashi, Katsushi Inoue,
published by
International Journal of Clinical Medicine,
Vol.3 No.2, 2012
has been cited by the following article(s):
|
[1]
|
Impact of Levetiracetam Treatment on 5-Aminolevulinic Acid Fluorescence Expression in IDH1 Wild-Type Glioblastoma
Cancers,
2022
DOI:10.3390/cancers14092134
|
|
|
|
|
[2]
|
Heme Biosynthesis mRNA Expression Signature: Towards a Novel Prognostic Biomarker in Patients with Diffusely Infiltrating Gliomas
Cancers,
2021
DOI:10.3390/cancers13040662
|
|
|
|
|
[3]
|
Dexamethasone alone and in combination with desipramine, phenytoin, valproic acid or levetiracetam interferes with 5-ALA-mediated PpIX production and cellular retention in glioblastoma cells
Journal of Neuro-Oncology,
2016
DOI:10.1007/s11060-015-2012-x
|
|
|
|
|
[4]
|
Quantification of Protoporphyrin IX Accumulation in Glioblastoma Cells: A New Technique
ISRN Surgery,
2014
DOI:10.1155/2014/405360
|
|
|
|